Product Launch (Blog)

Apr, 10 2023

Increasing Breast Cancer Prevalence is Growing the Adoption of Breast Reconstruction Surgeries Globally

 

As per the American Society of Plastic Surgeons (ASPS)/Plastic Surgery Foundation, around 101,600 women in the U.S. underwent breast reconstruction in 2018. The wide use of novel technology that enhances the comfort and safety of breast reconstruction surgeries and the huge availability of qualified plastic surgeons could improve the industry demand. Also, the growing products of innovative products are increasing the market's growth.

According to Data Bridge Market Research, the Middle East and Africa Breast Reconstruction Market was USD 567 million in 2021, would rise upto USD 917.44 million by 2029, and is expected to undergo a CAGR of 6.2% during the forecast period of 2022 to 2029.

"Increasing Prevalence of Breast Cancer Boost the Market Growth"

The growing incidence of breast cancer is the primary factor enhancing the market's growth. As per GLOBOCAN 2020, breast cancer enhanced lung cancer and became the most diagnosed cancer globally. As per the records of the WHO, in 2020, about 2.3 million women were diagnosed with breast cancer globally. Approximately 7.8 million women have been diagnosed with breast cancer over the last five years. In Asian women, breast cancer prevalence was high, accounting for 22.9% of the total cancer cases in women in 2020. Growing breast cancer cases is letting women undergo mastectomy and other breast cancer surgeries and go for the reconstruction process. This leads to the market growth rate.

What restraints the growth of the Middle East and Africa Breast Reconstruction Market?

"Side Effects of Breast Reconstruction"

Several complications lead to a huge market growth rate. High surgical expenditures and obstacles, such as unfavorable surgical effects, abnormal changes in nipple and breast sensation, scar development, and, in extreme cases, rupture with deflation of saline-filled implants linked with breast reconstructions, have restricted the market growth rate. These issues are associated with acellular dermal matrices (ADMs), such as skin necrosis, hematoma, and seroma, and are the most commonly reported complications after breast reconstruction procedures. Thus, this factor impedes market growth.

Segmentation: Middle East and Africa Breast Reconstruction Market

The breast reconstruction market is segmented on the basis of technology, type, reconstruction shape, placement, end-user and distribution channel.

  • Based on technology, the breast reconstruction market is segmented into inframammary, peri-areolar, trans-axillary, transumbilical.
  • Based on type, the market is segmented into alloplastic, autologous.
  • Based on reconstruction shape, the market is segmented into round implant shape, anatomical implant shape, round expander shape, anatomical expander shape.
  • Based on placement, the market is segmented into dual-plane insertion, subglandular insertion, submuscular insertion.
  • Based on end-user, the market is segmented into hospitals, clinics, ambulatory surgical centers.
  • Based on the distribution channel, the market is segmented into direct tenders, retail.

To know more about the study visit, https://www.databridgemarketresearch.com/reports/middle-east-and-africa-breast-reconstruction-market

Recent Developments in the Middle East and Africa Breast Reconstruction Market

  • In 2022, GC Aesthetics launched the Innovative Areola Complex reconstruction implant known as FixNip NRI. With this one-of-a-kind product, GC Aesthetics will expand and grow into the Breast Reconstruction Segment, increasing and enhancing current standards.

The Prominent Key Players Operating in the Middle East and Africa Breast Reconstruction Market Include:

  • POLYTECH Health & Aesthetics GmbH (Germany)
  • CEREPLAS (France)
  • Guangzhou Wanhe Plastic Materials Co., Ltd (China )
  • ALLERGAN (Ireland)
  • Johnson & Johnson Private Limited  (U.S)
  • GC Aesthetics (Ireland)
  • Laboratories Arion (France)
  • HansBioMed (South Korea)
  • Sientra, Inc. (U.S)
  • IDeal Implant Incorporated (U.S)
  • Integra LifeSciences (U.S)
  • RTI Surgical (U.S)
  • Sebbin (France)

Above are the key players covered in the report, to know about more and exhaustive list of Middle East and Africa breast reconstruction market companies contact, https://www.databridgemarketresearch.com/contact

Research Methodology: Middle East and Africa Breast Reconstruction Market

Data collection and base year analysis are done using data collection modules with large sample sizes. The market data is analyzed and estimated using market statistical and coherent models. In addition, market share analysis and key trend analysis are the major success factors in the market report. The key research methodology used by DBMR research team is data triangulation which involves data mining, analysis of the impact of data variables on the market, and primary (industry expert) validation. Apart from this, data models include Vendor Positioning Grid, Market Time Line Analysis, Market Overview and Guide, Company Positioning Grid, Company Market Share Analysis, Standards of Measurement, Middle East and Africa vs Regional and Vendor Share Analysis. Please request analyst call in case of further inquiry.


Client Testimonials